- Home
- BFS vs KURA Comparison
BFS vs KURA Comparison
Compare BFS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFS
- KURA
- Stock Information
- Founded
- BFS 1993
- KURA 2014
- Country
- BFS United States
- KURA United States
- Employees
- BFS N/A
- KURA N/A
- Industry
- BFS Real Estate Investment Trusts
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFS Real Estate
- KURA Health Care
- Exchange
- BFS Nasdaq
- KURA Nasdaq
- Market Cap
- BFS 828.5M
- KURA 700.5M
- IPO Year
- BFS 1993
- KURA N/A
- Fundamental
- Price
- BFS $33.94
- KURA $7.82
- Analyst Decision
- BFS
- KURA Strong Buy
- Analyst Count
- BFS 0
- KURA 13
- Target Price
- BFS N/A
- KURA $24.45
- AVG Volume (30 Days)
- BFS 53.4K
- KURA 2.0M
- Earning Date
- BFS 08-07-2025
- KURA 08-07-2025
- Dividend Yield
- BFS 6.91%
- KURA N/A
- EPS Growth
- BFS N/A
- KURA N/A
- EPS
- BFS 1.32
- KURA N/A
- Revenue
- BFS $277,902,000.00
- KURA $83,279,000.00
- Revenue This Year
- BFS $10.48
- KURA $60.25
- Revenue Next Year
- BFS $6.52
- KURA $155.10
- P/E Ratio
- BFS $25.89
- KURA N/A
- Revenue Growth
- BFS 5.23
- KURA N/A
- 52 Week Low
- BFS $31.25
- KURA $5.41
- 52 Week High
- BFS $42.39
- KURA $21.57
- Technical
- Relative Strength Index (RSI)
- BFS 58.45
- KURA 70.70
- Support Level
- BFS $33.58
- KURA $7.47
- Resistance Level
- BFS $34.23
- KURA $8.48
- Average True Range (ATR)
- BFS 0.54
- KURA 0.44
- MACD
- BFS 0.17
- KURA 0.12
- Stochastic Oscillator
- BFS 85.87
- KURA 86.15
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.